These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37890196)

  • 1. Assessing neuro-oncology clinical trial impact and value: Testing a novel multi-criteria decision analysis app.
    Field KM; Andrew Rosenthal M; Gillett P; IJzerman M
    J Clin Neurosci; 2023 Dec; 118():70-78. PubMed ID: 37890196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Priorities in Value-Based Cancer Care: Insights From the Alliance for Clinical Trials in Oncology National Cooperative Group Survey.
    Allen CJ; Snyder RA; Horn DM; Hudson MF; Barber A; Smieliauskas F; Spears PA; Edge S; Greenup RA
    JCO Oncol Pract; 2023 Oct; 19(10):932-938. PubMed ID: 37651652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value.
    Gillett P; Mahar RK; Tran NR; Rosenthal M; IJzerman M
    Cost Eff Resour Alloc; 2023 Nov; 21(1):87. PubMed ID: 37964269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient involvement in reflective multicriteria decision analysis to assist decision making in oncology.
    Badia X; Aguarón A; Fernández A; Gimón A; Nafria B; Gaspar B; Guarga L; Gálvez M; Fuentes M; Paco N; Saldaña R
    Int J Technol Assess Health Care; 2019 Jan; 35(1):56-63. PubMed ID: 30730288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
    Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
    Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing reflective multicriteria decision analysis (MCDA) to assess orphan drugs value in the Catalan Health Service (CatSalut).
    Guarga L; Badia X; Obach M; Fontanet M; Prat A; Vallano A; Torrent J; Pontes C
    Orphanet J Rare Dis; 2019 Jun; 14(1):157. PubMed ID: 31248421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "They Can't Believe They're a Tiger": Insights from pediatric speech-language pathologist mobile app users and app designers.
    Du Y; Lubniewski K; Price L; Breslin G; Thomson P; Jinadasa N; Soni N
    Int J Lang Commun Disord; 2023; 58(5):1717-1737. PubMed ID: 37219400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicians' experiences of using and implementing a medical mobile phone app (QUiPP V2) designed to predict the risk of preterm birth and aid clinical decision making.
    Carlisle N; Watson HA; Carter J; Kuhrt K; Seed PT; Tribe RM; Sandall J; Shennan AH
    BMC Med Inform Decis Mak; 2021 Nov; 21(1):320. PubMed ID: 34794405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the feasibility of a mobile health-supported clinical decision support system for nutritional triage in oncology outpatients using Arden Syntax.
    de Bruin JS; Schuh C; Seeling W; Luger E; Gall M; Hütterer E; Kornek G; Ludvik B; Hoppichler F; Schindler K
    Artif Intell Med; 2018 Nov; 92():34-42. PubMed ID: 26563776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of the Patient Preference Assessment Tool on clinicians' recommendations for phase I oncology clinical trials.
    Hianik RS; Owonikoko T; Switchenko J; Dixon MD; Shaib WL; Pentz RD
    Psychooncology; 2021 Oct; 30(10):1739-1744. PubMed ID: 34038982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating evidence and individual preferences using a web-based multi-criteria decision analytic tool: an application to prostate cancer screening.
    Cunich M; Salkeld G; Dowie J; Henderson J; Bayram C; Britt H; Howard K
    Patient; 2011; 4(3):153-62. PubMed ID: 21766911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicians' Role in the Adoption of an Oncology Decision Support App in Europe and Its Implications for Organizational Practices: Qualitative Case Study.
    Jacob C; Sanchez-Vazquez A; Ivory C
    JMIR Mhealth Uhealth; 2019 May; 7(5):e13555. PubMed ID: 31066710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA).
    Rutten-van Mölken M; Leijten F; Hoedemakers M; Tsiachristas A; Verbeek N; Karimi M; Bal R; de Bont A; Islam K; Askildsen JE; Czypionka T; Kraus M; Huic M; Pitter JG; Vogt V; Stokes J; Baltaxe E;
    BMC Health Serv Res; 2018 Jul; 18(1):576. PubMed ID: 30041653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the utility and attitudes toward molecular testing in neuro-oncology: a survey of the Society for Neuro-Oncology members.
    Fortin Ensign S; Hrachova M; Chang S; Mrugala MM
    Neurooncol Pract; 2021 Jun; 8(3):310-316. PubMed ID: 34055378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provider-reported challenges and barriers to referring patients to neuro-oncology clinical trials: a report from the Society for Neuro-Oncology member survey.
    Rogers JL; Acquaye A; Vera E; Bates A; Wen PY; Armstrong TS
    Neurooncol Pract; 2020 Jan; 7(1):38-51. PubMed ID: 32257283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple criteria decision analysis in the context of health technology assessment: a simulation exercise on metastatic colorectal cancer with multiple stakeholders in the English setting.
    Angelis A; Montibeller G; Hochhauser D; Kanavos P
    BMC Med Inform Decis Mak; 2017 Oct; 17(1):149. PubMed ID: 29073892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.